These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 22273830)
21. The failing heart and the hemodynamic response to vasodilator therapy. Mills RM Clin Cardiol; 2003 Jun; 26(6):257-8. PubMed ID: 12839041 [No Abstract] [Full Text] [Related]
22. [Vasodilator therapy of heart failure]. Mathey D Dtsch Med Wochenschr; 1979 Apr; 104(16):563-4. PubMed ID: 108068 [No Abstract] [Full Text] [Related]
23. Pharmacotherapy for acute heart failure syndromes. Coons JC; McGraw M; Murali S Am J Health Syst Pharm; 2011 Jan; 68(1):21-35. PubMed ID: 21164062 [TBL] [Abstract][Full Text] [Related]
24. [Recent progress in the treatment of cardiac insufficiency. Contribution of vasodilator agents]. Ivanciuc I Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):385-92. PubMed ID: 44561 [No Abstract] [Full Text] [Related]
26. Vasodilators for chronic congestive heart failure. Med Lett Drugs Ther; 1988 Jan; 30(758):13-4. PubMed ID: 3277025 [No Abstract] [Full Text] [Related]
27. Management of chronic heart failure: an old disease with a new face. Prendergast HM; Bunney EB Emerg Med Australas; 2005 Apr; 17(2):143-51. PubMed ID: 15796729 [TBL] [Abstract][Full Text] [Related]
28. Vasodilator therapy of cardiac failure: (first of two parts). Cohn JN; Franciosa JA N Engl J Med; 1977 Jul; 297(1):27-31. PubMed ID: 405585 [No Abstract] [Full Text] [Related]
29. [Circulatory failure in children with left-to-right shunt in the framework of congenital heart defects: pathophysiology and therapeutic results]. Wessel A; Buchhorn R; Bürsch J Klin Padiatr; 2000; 212(2):53-9. PubMed ID: 10812553 [TBL] [Abstract][Full Text] [Related]
30. Current indications for vasodilator therapy for left ventricular failure. Franciosa JA Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926 [No Abstract] [Full Text] [Related]
31. Should we inhibit angiotensin-converting enzymes in acute heart failure? Lamond NW; Howlett JG Heart Fail Monit; 2007; 5(3):70-6. PubMed ID: 17487295 [TBL] [Abstract][Full Text] [Related]
32. Can prognosis be altered by treating LV dysfunction? Elkayam U Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III58-64. PubMed ID: 2575022 [TBL] [Abstract][Full Text] [Related]
33. The role of vasodilator therapy in the management of the patient with acute myocardial infarction. Wagner GC; Robinson PH Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986 [No Abstract] [Full Text] [Related]
34. Pharmacologic management of heart failure caused by systolic dysfunction. Chavey WE; Bleske BE; Van Harrison R; Hogikyan RV; Kesterson SK; Nicklas JM Am Fam Physician; 2008 Apr; 77(7):957-64. PubMed ID: 18441861 [TBL] [Abstract][Full Text] [Related]
35. The role of vasodilators in managing congestive heart failure. Franciosa JA Postgrad Med; 1980 Jan; 67(1):87-91, 94-8. PubMed ID: 6765989 [TBL] [Abstract][Full Text] [Related]
36. Evidence-based drug treatment of heart failure. Wasson S; Fleming D; Reddy HK Mo Med; 2005; 102(6):540-8; quiz 548-9. PubMed ID: 16355640 [TBL] [Abstract][Full Text] [Related]
37. Congestive heart failure. Drug therapy: central or peripheral approach? Remme WJ Cardiologia; 1993 Dec; 38(12 Suppl 1):51-9. PubMed ID: 7912652 [TBL] [Abstract][Full Text] [Related]